How Strong Is ProPhase Labs' Balance Sheet? According to the last reported balance sheet, ProPhase Labs had liabilities of US$16.7m due within 12 months, and liabilities of US$13.1m due beyond 12 ...
$201.2 Million in Gross Claims with Expanding Settlement Activity Across Multiple Insurance Carriers Active Negotiations Support Estimated $50–$60 Million Net Recovery and Near-Term Cash Flow ...
Welcome to today's presentation. My name is Noella Alexander-Young, virtual event moderator here at Renmark Financial Communications. On behalf of our team, we want to thank everyone for joining us ...
UNIONDALE, NY, Feb. 02, 2026 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (OTC: PRPH) (“ProPhase” or the “Company”) is pleased to invite investors to a webinar on Tuesday, February 3, 2026, at 4:15 p.m. ET ...
Company Actively Pursuing Strategic Alternatives Including the Potential Sale of Nebula Genomics and DNA Complete to Unlock Immediate Cash GARDEN CITY, NY, Feb. 20, 2025 (GLOBE NEWSWIRE) -- ProPhase ...
In a challenging market environment, ProPhase Labs, Inc. (PRPH) stock has touched a 52-week low, dipping to $2.02. This price level reflects a significant downturn for the company, which has seen its ...
ProPhase Labs, Inc. PRPH shares soared 11.2% in the last trading session to close at $8.13. The move was backed by solid volume with far more shares changing hands than in a normal session. This ...
Any future issuance of shares under the agreement would occur solely at ProPhase Labs’ election and in accordance with applicable securities laws. The securities described in the agreement were issued ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results